Bayer Investor Relations

Team having a chat
Investor News
Share Price / Index
May 23, 2025
Not intended for U.S. and UK Media
Eylea™ 8 mg with extended 6-month treatment interval recommended for approval in EU
May 22, 2025
Not intended for U.S. and UK Media
Eylea™ 8 mg approved in China for wet age-related macular degeneration
May 13, 2025
First-quarter performance:
Bayer confirms 2025 targets after solid start to the year